BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 1st Quarter - Report

STRAND THERAPEUTICS

via SACHEM STRATEGIES

1st Quarter (Jan 1 - Mar 31) · 2026Posted Apr 21, 2026Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: STRAND THERAPEUTICS
Description: mRNA therapeutics company
Location: Massachusetts · United States of America

Registrant

Firm: SACHEM STRATEGIES
Description: Lobbying firm
Location: Boston, Massachusetts, United States of America

Lobbying activities

1 issue

Health Issues
Issues related to biomanufacturing policy (no specific legislation).
LobbyistsNATHANIEL WALTON
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Health & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

STRAND THERAPEUTICS — Lobbying — Receipts Report